Herzuma (trastuzumab) Injection, 420 mg/Vial, Single-Dose Vial
Herzuma is a sterile, preservative-free injectable formulation of trastuzumab, a HER2/neu receptor antagonist used in the treatment of HER2-overexpressing breast cancer and metastatic gastric cancer. Each single-dose vial contains 420 mg of trastuzumab as a lyophilized powder for reconstitution and intravenous administration. This product is supplied by Teva Pharmaceuticals as a prescription medication.
Vendor Pricing Comparison
Sorted by lowest price · Add now, sign in at checkout
Vendor Pricing Comparison
Sorted by lowest price · Add now, sign in at checkout
Herzuma is a sterile, preservative-free injectable formulation of trastuzumab, a HER2/neu receptor antagonist used in the treatment of HER2-overexpressing breast cancer and metastatic gastric cancer. Each single-dose vial contains 420 mg of trastuzumab as a lyophilized powder for reconstitution and intravenous administration. This product is supplied by Teva Pharmaceuticals as a prescription medication.
1 vendor
